Optics Outfitter
Why this eyewear company’s advertised “starting” prices may not be 20/20.
Amyloban 3399
March 2016: This action was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons have not been disclosed.
January 2016: A class-action lawsuit was filed against Mushroom Wisdom for allegedly deceptively marketing the supplement Amyloban 3399 as an effective therapy for the prevention of brain disease – including Alzheimer’s Disease – when, in reality, such claims are not true and in violation of federal law. The lawsuit was transferred to federal court in February 2016. (Hoffman et al v. Mushroom Wisdom, Inc., Case No. 16-cv-768, D. NJ.)
For more information about other class-action lawsuits regarding brain supplements and TINA.org’s coverage of the products, click here.
The Latest
Court Order Forces Prevagen to Scrub Memory-Improvement Claims
MADISON, CONN. Dec. 12, 2024— In a win for consumers, a court has ordered Quincy Bioscience to stop advertising Prevagen using memory-improvement claims. This follows a near-decade-long campaign by the…
Prevagen Scrubs Memory-Improvement Claims Following Court Order
What led up to brain supplement’s December to remember.
The Perimenopause Gold Rush
Jessica Bennett, The Cut
Friday Plans
Getting lucky for this cheap may be harder than you think.